scalability

Digital

Why AI sovereignty is becoming a requirement for businesses

The companies that will lead in this next phase are those that treat AI as an integrated part of their operational architecture.

Digital

AI, trust, and transformation: What the NHS needs for safe a...

As AI becomes more embedded within national health system priorities, the need for clear and responsible guardrails has become increasingly critical.

R&D

Scientist using manual and AI methods in lab

From in silico to in vivo: Why development strategy now dete...

As discovery becomes faster and more accessible, the differentiator shifts downstream.

Sales & Marketing

Swiss train speeding across bridge against landscape background

A fast start to 2026 signals continued investor confidence i...

Key factors in Switzerland’s success that could make other European life sciences hubs more attractive to investors.

R&D

The impact of generative AI on protein design for drug disco...

Artificial Intelligence (AI) is at the heart of the latest global transformation, not least within the biopharmaceutical industry.

Digital

embracing AI illustration of man on hand

Biopharma’s AI rally: Readiness not hype in 2025

The drumbeat of AI advancements over the last year has left us all breathless, wondering which benchmark will be broken next and which new problems we can solve in biology.

Why AI sovereignty is becoming a requirement for businesses

AI, trust, and transformation: What the NHS needs for safe a...

From in silico to in vivo: Why development strategy now dete...

A fast start to 2026 signals continued investor confidence i...

The impact of generative AI on protein design for drug disco...

Biopharma’s AI rally: Readiness not hype in 2025

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

scalability

Editor's Picks